Suven's Pashamylaram's unit receives US FDA acceptance

22 Jan 2014 Evaluate

Suven Life Sciences an ISO 9001, ISO 14001 and OHSAS 18001 company has received United States Food and Drugs Administration (US FDA) acceptance for its facility in Pashamylaram, near Hyderabad. The company has undergone US FDA renewal inspection at their facility in Pashamylaram for the manufacture and supply of active pharmaceutical ingredients (bulk drugs), ntermediates and formulations under cGMP.

Based on the inspection and the review thereafter US-FDA has classified Suven facility at Pashamylaram as acceptable for manufacture and supply of active pharmaceutical ingredients, intermediates and formulations. So far Suven Life Sciences has filed 29 DMF’s and 1 ANDA from this facility which is FDA complaint under cGMP and continued after renewal inspection.

Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.

Suven Life Sciences Share Price

170.15 -1.25 (-0.73%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×